Global Endogenous Creatinine Assay Kits Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Endogenous Creatinine Assay Kits market size was valued at US$ 221 million in 2024 and is forecast to a readjusted size of USD 310 million by 2031 with a CAGR of 5.0% during review period.

Endogenous Creatinine Assay Kit can measure creatinine levels in urine, serum, and culture media samples. This test is done to see how well your kidneys are working. Creatinine can also be measured with a urine test. A measurement of the serum creatinine level is often used to evaluate kidney function.

Creatinine testing is performed using specific creatinine testing kits that can be done for a number of reasons, including high blood pressure, diabetes, and cancer. According to the International Society of Nephrology, approximately 13.3 million cases of acute kidney injury (AKI) occur each year worldwide, with an annual incidence of 11.3 million in emerging countries. Rising incidence of kidney diseases and other chronic diseases, technological developments in biomedical research related to kidney diseases, and rising R&D activities drive the creatinine assay kits market. The creatinine test is one of the most sensitive methods for determining the glomerular filtration rate of the kidneys. For this reason, the creatinine test is the test most commonly used to assess kidney function. Direct and automated methods for measuring creatinine levels in biological samples are becoming increasingly common in research and drug discovery. Therefore, the use of creatinine measurements to detect kidney disease is becoming more and more popular worldwide. The Creatinine Assay Kit is used to detect creatinine in biological samples without any pretreatment. Advances in measuring creatinine levels may help in the early detection of kidney disease. Growing demand for mycobacteria testing in urine and increasing geriatric population suffering from renal failure are two factors driving the demand for creatinine testing kits market. The global creatinine test kit market is likely to be driven by high prevalence of chronic kidney disease (CKD) and diabetes, growing geriatric population, and rising R&D activities. Furthermore, the introduction of exogenous labeling elements, increasing government financing, and high volume of clinical laboratory activities are driving the global creatinine test kits market.

This report is a detailed and comprehensive analysis for global Endogenous Creatinine Assay Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Endogenous Creatinine Assay Kits market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Endogenous Creatinine Assay Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Endogenous Creatinine Assay Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Endogenous Creatinine Assay Kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Endogenous Creatinine Assay Kits

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Endogenous Creatinine Assay Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Siemens Healthineers, Abbott, Leadman Biochemis, Kanto Chemica, Chondrex, Beijing Leadman Biochemistry, Maccura Biotechnology, Shenzhen Goldsite Diagnostics, Beijing Solarbio Science & Technology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Endogenous Creatinine Assay Kits market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Jaffe's Kinetic Method
Enzymatic Method

Market segment by Application
Hospital
Laboratories

Major players covered
Roche
Siemens Healthineers
Abbott
Leadman Biochemis
Kanto Chemica
Chondrex
Beijing Leadman Biochemistry
Maccura Biotechnology
Shenzhen Goldsite Diagnostics
Beijing Solarbio Science & Technology
Beijing Strong Biotechnologies
Ningbo Ruiyuan Biotechnology
Shanghai Fosun Pharmaceutical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Endogenous Creatinine Assay Kits product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Endogenous Creatinine Assay Kits, with price, sales quantity, revenue, and global market share of Endogenous Creatinine Assay Kits from 2020 to 2025.

Chapter 3, the Endogenous Creatinine Assay Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Endogenous Creatinine Assay Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Endogenous Creatinine Assay Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Endogenous Creatinine Assay Kits.

Chapter 14 and 15, to describe Endogenous Creatinine Assay Kits sales channel, distributors, customers, research findings and conclusion.